181 related articles for article (PubMed ID: 30129051)
1. The prognostic value of long noncoding RNA MEG3 expression in the survival of patients with cancer: A meta-analysis.
Binabaj MM; Bahrami A; Bahreyni A; Shafiee M; Rahmani F; Khazaei M; Soleimanpour S; Ghorbani E; Fiuji H; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
J Cell Biochem; 2018 Nov; 119(11):9583-9590. PubMed ID: 30129051
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies.
Xue Y; Teng YQ; Zhou JD; Rui YJ
Tumour Biol; 2016 Jan; 37(1):1211-5. PubMed ID: 26282005
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of long non-coding RNA MEG3 indicates an unfavorable prognosis in non-small cell lung cancer: Evidence from the GEO database.
Zhang Z; Liu T; Wang K; Qu X; Pang Z; Liu S; Liu Q; Du J
Gene; 2017 Sep; 630():49-58. PubMed ID: 28782577
[TBL] [Abstract][Full Text] [Related]
4. Mining Prognostic Significance of MEG3 in Human Breast Cancer Using Bioinformatics Analysis.
Cui X; Yi Q; Jing X; Huang Y; Tian J; Long C; Xiang Z; Liu J; Zhang C; Tan B; Li Y; Zhu J
Cell Physiol Biochem; 2018; 50(1):41-51. PubMed ID: 30278461
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA MEG3 regulates proliferation, apoptosis, and autophagy and is associated with prognosis in glioma.
Zhao H; Wang X; Feng X; Li X; Pan L; Liu J; Wang F; Yuan Z; Yang L; Yu J; Su R; Zhang Y; Ma L
J Neurooncol; 2018 Nov; 140(2):281-288. PubMed ID: 30284203
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA MEG3, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis.
Cui X; Jing X; Long C; Tian J; Zhu J
Oncotarget; 2017 Mar; 8(12):19049-19056. PubMed ID: 28157702
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Long Noncoding RNAs in Patients with Gastrointestinal Cancer: A Systematic Review and Meta-Analysis.
Kang W; Zheng Q; Lei J; Chen C; Yu C
Dis Markers; 2018; 2018():5340894. PubMed ID: 30598708
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer.
Yin DD; Liu ZJ; Zhang E; Kong R; Zhang ZH; Guo RH
Tumour Biol; 2015 Jun; 36(6):4851-9. PubMed ID: 25636452
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer.
Wang W; Xie Y; Chen F; Liu X; Zhong LL; Wang HQ; Li QC
World J Gastroenterol; 2019 Aug; 25(29):3972-3984. PubMed ID: 31413531
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.
Wang J; Du S; Wang J; Fan W; Wang P; Zhang Z; Xu P; Tang S; Deng Q; Yang W; Yu M
PLoS One; 2017; 12(6):e0179670. PubMed ID: 28658310
[TBL] [Abstract][Full Text] [Related]
11. Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer.
Bayarmaa B; Wu Z; Peng J; Wang Y; Xu S; Yan T; Yin W; Lu J; Zhou L
BMC Cancer; 2019 Sep; 19(1):877. PubMed ID: 31488093
[TBL] [Abstract][Full Text] [Related]
12. Integrated Analysis Reveals That Long Non-Coding RNA TUBA4B Can Be Used as a Prognostic Biomarker in Various Cancers.
Zhang T; Wu DM; Deng SH; Han R; Liu T; Li J; Xu Y
Cell Physiol Biochem; 2018; 49(2):530-544. PubMed ID: 30157490
[TBL] [Abstract][Full Text] [Related]
13. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA UCA1 Overexpression Is Associated with Poor Prognosis in Digestive System Malignancies: A Meta-analysis.
Shi FT; Chen LD; Zhang LF
Curr Med Sci; 2019 Oct; 39(5):694-701. PubMed ID: 31612385
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis.
Liu C; Jin J; Shi J; Wang L; Gao Z; Guo T; He Y
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30918102
[No Abstract] [Full Text] [Related]
16. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
[TBL] [Abstract][Full Text] [Related]
17. TUG1, SPRY4-IT1, and HULC as valuable prognostic biomarkers of survival in cancer: A PRISMA-compliant meta-analysis.
Zhong Y; Chen Z; Guo S; Liao X; Xie H; Zheng Y; Cai B; Huang P; Liu Y; Zhou Q; Liu Y; Huang W
Medicine (Baltimore); 2017 Nov; 96(46):e8583. PubMed ID: 29145271
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic value of lncRNA PANDAR expression in solid tumors: Evidence from a systematic review and meta-analysis.
Mehrad-Majd H; Akhtari J; Haerian MS; Ravanshad Y
J Cell Physiol; 2019 Apr; 234(4):4206-4216. PubMed ID: 30191982
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA X-inactive specific transcript as a prognostic factor in cancer patients: A meta-analysis based on retrospective studies.
Chen J; Yang X; Gong D; Cui Y; Hu J; Li H; Liu P; Li C; Cheng X; Liu L; Chen H; Zu X
Medicine (Baltimore); 2019 Jan; 98(3):e14095. PubMed ID: 30653128
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway.
Gao Y; Lu X
Tumour Biol; 2016 Feb; 37(2):1461-9. PubMed ID: 26662307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
